Viatris Completes Acquisition of Pacira BioSciences
Viatris · Company update · November 17, 2026
The deal adds established treatments for acute postsurgical pain and osteoarthritis knee pain to the company's innovative medicines portfolio.
AntSpace’s summary of Viatris’s own announcement: read the original.